EAN 2022 | EAN/MDS guideline on invasive therapies for Parkinson’s disease

Lars Wojtecki, MD, PhD, Institute of Clinical Neuroscience and Medical Psychology, University Düsseldorf, Düsseldorf, Germany, outlines the importance of the development of the European Academy of Neurology/Movement Disorder Society-European Section guideline on invasive therapies for the treatment of Parkinson’s disease. The guideline included interventions requiring surgery or invasive medication delivery, which are usually considered for advanced disease and include deep brain stimulation (DBS), pump therapies, and lesional therapies for the treatment of Parkinson’s disease. The development of this guideline is an essential step in the harmonization of Parkinson’s disease treatment across Europe. This interview took place at the European Academy of Neurology (EAN) 2022 Congress in Vienna, Austria.